Guggenheim Capital LLC Edwards Lifesciences Corp Transaction History

Guggenheim Capital LLC

$14 Billion
Q1 2024

A detailed history of Guggenheim Capital LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 211,215 shares of EW stock, worth $19.2 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

211,215

Previous 207,129 1.97%

Holding current value

$19.2 Million

Previous $15.8 Million 27.8%

% of portfolio

0.14%

Previous 0.12%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $296,398 - $390,458	4,086 Added 1.97%	211,215 $20.2 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $440,547 - $555,128	7,139 Added 3.57%	207,129 $15.8 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $2.4 Million - $3.24 Million	-34,644 Reduced 14.77%	199,990 $13.9 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $342,491 - $396,846	-4,207 Reduced 1.76%	234,634 $22.1 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $285,529 - $324,940	3,845 Added 1.64%	238,841 $19.8 Million

Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $2.26 Million - $2.9 Million	33,144 Added 16.42%	234,996 $17.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.61 Million - $2.1 Million	19,541 Added 10.72%	201,852 $16.7 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $403,782 - $598,764	-4,668 Reduced 2.5%	182,311 $17.3 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $2.97 Million - $3.74 Million	-29,131 Reduced 13.48%	186,979 $22 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $4.49 Million - $5.52 Million	42,212 Added 24.27%	216,110 $28 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $1.5 Million - $1.79 Million	14,602 Added 9.17%	173,898 $19.7 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $1.21 Million - $1.51 Million	-14,455 Reduced 8.32%	159,296 $16.5 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $695,688 - $801,704	8,842 Added 5.36%	173,751 $14.5 Million
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $167,109 - $212,657	-2,331 Reduced 1.39%	164,909 $15 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $1.04 Million - $1.35 Million	15,479 Added 10.2%	167,240 $13.3 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $5.62 Million - $7.51 Million	97,621 Added 180.31%	151,761 $10.5 Million
Q1 2020 Jun 02, 2020	BUY	$52.41 - $81.0 $956,272 - $1.48 Million	18,246 Added 50.83%	54,140 $10.2 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $1.42 Million - $1.63 Million	-19,855 Reduced 35.61%	35,894 $8.37 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $1.33 Million - $1.63 Million	-21,643 Reduced 27.97%	55,749 $12.3 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $464,704 - $536,986	-8,337 Reduced 9.72%	77,392 $14.3 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $941,421 - $1.26 Million	-19,658 Reduced 18.65%	85,729 $16.4 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $665,380 - $816,348	-14,337 Reduced 11.98%	105,387 $16.1 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $588,387 - $747,136	12,875 Added 12.05%	119,724 $20.8 Million
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $20.5 Million - $24.8 Million	-483,935 Reduced 81.91%	106,849 $15.6 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $2.3 Million - $2.93 Million	-61,757 Reduced 9.46%	590,784 $82.4 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $3 Million - $3.5 Million	88,931 Added 15.78%	652,541 $73.5 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $20.5 Million - $21.9 Million	563,610	563,610 $61.6 Million

Others Institutions Holding EW

# of Institutions

1,377

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Edwards Lifesciences Corp Transaction History